Protective effect of Taraxasterol (cas 1059-14-9) on acute lung injury induced by lipopolysaccharide in mice
-
Add time:07/30/2019 Source:sciencedirect.com
Taraxasterol (cas 1059-14-9), a pentacyclic-triterpene isolated from Taraxacum officinale, has been reported to have potent anti-inflammatory properties. However, the effect of taraxasterol on lipopolysaccharide (LPS)-induced mice acute lung injury has not been investigated. The aims of this study were to investigate whether taraxasterol could ameliorate the inflammation response in LPS-induced acute lung injury and to clarify the possible mechanism. Male BALB/c mice were pretreated with taraxasterol 1 h before intranasal instillation of LPS. 7 h after LPS administration, the myeloperoxidase (MPO) in lung tissues, lung wet/dry ratio and inflammatory cells in the bronchoalveolar lavage fluid (BALF) were detected. The levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β) in the BALF were measured by ELISA. The extent of phosphorylation of IκB-α, p65 NF-κB, p46–p54 JNK, p42–p44 ERK, and p38 were determined by western blotting. The results showed that taraxasterol attenuated the infiltration of inflammatory cells, the activity of myeloperoxidase (MPO), lung wet/dry ratio, and the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in a dose-dependent manner. Additionally, western blotting results showed that taraxasterol inhibited the phosphorylation of IκB-α, p65 NF-κB, p46–p54 JNK, p42–p44 ERK, and p38 caused by LPS. Our data suggest that anti-inflammatory effects of taraxasterol against the LPS-induced ALI may be due to its ability of inhibition of the NF-κB and MAPK signaling pathways.
We also recommend Trading Suppliers and Manufacturers of Taraxasterol (cas 1059-14-9). Pls Click Website Link as below: cas 1059-14-9 suppliers
Prev:Effects of Taraxasterol (cas 1059-14-9) on ovalbumin-induced allergic asthma in mice
Next:Effects of Taraxasterol (cas 1059-14-9) on inflammatory responses in lipopolysaccharide-induced RAW 264.7 macrophages) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Optimization of methyl jasmonate and β-cyclodextrin for enhanced production of taraxerol and Taraxasterol (cas 1059-14-9) in (Taraxacum officinale Weber) cultures08/02/2019
- Effects of Taraxasterol (cas 1059-14-9) on iNOS and COX-2 expression in LPS-induced RAW 264.7 macrophages08/01/2019
- Effects of Taraxasterol (cas 1059-14-9) on inflammatory responses in lipopolysaccharide-induced RAW 264.7 macrophages07/31/2019
- Effects of Taraxasterol (cas 1059-14-9) on ovalbumin-induced allergic asthma in mice07/29/2019
- Taraxasterol (cas 1059-14-9) inhibits cigarette smoke-induced lung inflammation by inhibiting reactive oxygen species-induced TLR4 trafficking to lipid rafts07/28/2019
- Taraxasterol (cas 1059-14-9) inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes07/27/2019
- Anti-inflammatory and anti-arthritic effects of Taraxasterol (cas 1059-14-9) on adjuvant-induced arthritis in rats07/26/2019
- Taraxasterol (cas 1059-14-9) suppresses inflammation in IL-1β-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice07/25/2019
- Network pharmacology-based identification of the protective mechanisms of Taraxasterol (cas 1059-14-9) in experimental colitis07/24/2019